Skip to main content
. 2020 Jan 22;5(3):282–290. doi: 10.1001/jamacardio.2019.5315

Table 1. Propensity Score and Clinical Characteristics.

Variable Frequency, No. (%) P Value
ACS Group (n = 189) Control Group (n = 189)
Included in propensity score
Age, mean (SD), y 59.6 (10.3) 60.3 (9.3) .33
Male sex 126 (66.7) 121 (64.0) .33
Diabetes 37 (19.6) 57 (30.2) .006
Hypertension 116 (62.0) 106 (56.1) .21
Hyperlipidemia 105 (55.6) 102 (54.0) .82
Familial history of CAD 80 (43.5) 78 (41.3) .44
Current smoker 56 (29.6) 43 (22.8) .09
CAD severity
None 13 (7.3) 25 (13.2) .06
Nonobstructive 69 (38.8) 75 (39.7)
1-Vessel obstructive 26 (14.6) 38 (20.1)
2-Vessel obstructive 31 (17.4) 21 (11.1)
3-Vessel/left main obstructive 39 (21.9) 30 (15.9)
Angina type
Asymptomatic 25 (14.0) 64 (35.0) .001
Noncardiac 20 (11.2) 23 (12.6)
Atypical 8 (47.8) 69 (37.7)
Typical 48 (27.0) 27 (14.8)
Race/ethnicity
White 85 (62.0) 89 (62.2) .59
East Asian 43 (31.4) 42 (29.4)
Other 9 (6.6) 12 (8.4)
Lipid profile, mean (SD), mg/dL
Cholesterol
Total 190.0 (48.2) 186.7 (40.7) .67
Low-density lipoprotein 116.6 (42.6) 119.2 (32.1) .78
High-density lipoprotein 43.5 (10.9) 47.8 (13.2) .09
Medications
Statins 75 (58.1) 64 (49.2) .24
Aspirin 73 (52.5) 66 (47.5) .78
ACEI/ARB 51 (37.0) 52 (37.4) >.99
β-Blocker 49 (35.5) 49 (35.3) .79
Interval coronary revascularization 92 (48.7) 42 (22.2) <.001
ACS type
Myocardial infarction
ST-segment elevation 33 (17.5) NA NA
Non–ST-segment elevation 90 (47.6) NA NA
Unclassified 3 (1.6) NA NA
Unstable angina 63 (33.0) NA NA

Abbreviations: ACEI, angiotensin-converting enzyme inhibitor; ACS, acute coronary syndrome; ARB, angiotensin receptor blocker; CAD, coronary artery disease; NA, not applicable.

SI conversion factor: To convert cholesterol levels to millimoles per liter, multiply by 0.0259.